Catalyst Wire Dossier Catalyst Wire Dossier

AVSOLA

Infliximab-axxq · Amgen, Inc
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for AVSOLA, covering 2019-12-06 to 2025-08-25. Get the full timeline:

Most recent: FDA Approved: AVSOLA — Supplemental Application (Amgen, Inc)

See pricing